AVeta Medical Appoints Karen Noblett as New CEO [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
Eileen Duffy, who served as interim CEO, has been appointed Chair of the Board of Directors. "Karen's deep experience leading clinical programs, guiding regulatory strategy, and scaling med-tech innovation aligns directly with AVeta's next phase of growth," said Eileen Duffy, incoming Chair of AVeta's Board of Directors. A nationally recognized leader in urogynecology and pelvic floor disorders, Dr. Noblett brings more than 25 years of clinical, academic, and medical technology experience to AVeta Medical. Most recently, she served as Chief Medical Officer at Axonics, where she advanced the company's leadership in sacral neuromodulation. She oversaw clinical strategy, evidence generation, physician education, and programs that supported rapid adoption of Axonics technologies across U.S. and international markets—experience that provides a strong foundation for scaling AVeta's clinical, regulatory, and commercial strategy. Before transitioning to industry, Dr. Noblett spent nearl
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Boston Scientific (NYSE:BSX) was given a new $131.00 price target on by analysts at Canaccord Genuity Group Inc..MarketBeat
- Boston Scientific (NYSE:BSX) had its price target raised by analysts at Royal Bank Of Canada from $125.00 to $130.00. They now have an "outperform" rating on the stock.MarketBeat
- Pulling back 5.1% this week, Boston Scientific's NYSE:BSX) five-year decline in earnings may be coming into investors focus [Yahoo! Finance]Yahoo! Finance
- Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at Cowen Inc.MarketBeat
BSX
Earnings
- 10/22/25 - Beat
BSX
Sec Filings
- 12/8/25 - Form 3
- 12/2/25 - Form 4
- 12/1/25 - Form 4
- BSX's page on the SEC website